Cargando…
Engineering ACE2 decoy receptors to combat viral escapability
Decoy receptor proteins that trick viruses to bind to them should be resistant to viral escape because viruses that require entry receptors cannot help but bind decoy receptors. Angiotensin-converting enzyme 2 (ACE2) is the major receptor for coronavirus cell entry. Recombinant soluble ACE2 was prev...
Autores principales: | Arimori, Takao, Ikemura, Nariko, Okamoto, Toru, Takagi, Junichi, Standley, Daron M., Hoshino, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312672/ https://www.ncbi.nlm.nih.gov/pubmed/35902282 http://dx.doi.org/10.1016/j.tips.2022.06.011 |
Ejemplares similares
-
An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo
por: Ikemura, Nariko, et al.
Publicado: (2022) -
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
por: Higuchi, Yusuke, et al.
Publicado: (2021) -
A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo
por: Havranek, Brandon, et al.
Publicado: (2023) -
Cis-regulatory decoy disrupts autorepression: a potential escape-resistant anti-viral therapy
por: Hu, Jia, et al.
Publicado: (2022) -
Engineered fast-dissociating antibody fragments for multiplexed super-resolution microscopy
por: Zhang, Qianli, et al.
Publicado: (2022)